• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Is the prevalence of dementia changing?

作者信息

Beard C M, Kokmen E, Offord K, Kurland L T

机构信息

Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905.

出版信息

Neurology. 1991 Dec;41(12):1911-4. doi: 10.1212/wnl.41.12.1911.

DOI:10.1212/wnl.41.12.1911
PMID:1745347
Abstract

We compared the point prevalence rates of dementing illnesses in the population of Rochester, Minnesota, on January 1, 1980, with the previously published rates of January 1, 1975, by using extensive health care records available from all sources of care in the community, in order to identify and classify cases with standard diagnostic criteria derived from DSM-III. The overall age- and sex-adjusted prevalence rate per 100,000 population for dementia on January 1, 1980, was 402.5 compared with 388.4 on January 1, 1975; for Alzheimer's disease it was 259.8 in 1980 and 259.5 in 1975. The stability of the rates suggests no change in the incidence and mortality associated with these conditions. The prevalence rates for Rochester, Minnesota, are similar to many other rates estimated in other North American communities, but they differ from two other population-based estimates from East Boston and California. Case definitions and methods of assessment probably account for the differences in estimated prevalence.

摘要

相似文献

1
Is the prevalence of dementia changing?
Neurology. 1991 Dec;41(12):1911-4. doi: 10.1212/wnl.41.12.1911.
2
The prevalence of dementia is changing over time in Rochester, Minnesota.
Neurology. 1995 Jan;45(1):75-9. doi: 10.1212/wnl.45.1.75.
3
Epidemiology of dementia in Rochester, Minnesota.明尼苏达州罗切斯特市的痴呆症流行病学。
Mayo Clin Proc. 1996 Mar;71(3):275-82. doi: 10.4065/71.3.275.
4
Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, January 1, 1975.
Neurology. 1989 Jun;39(6):773-6. doi: 10.1212/wnl.39.6.773.
5
Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960-1984).痴呆症的发病率在变化吗?明尼苏达州罗切斯特市的一项为期25年的时间趋势研究(1960 - 1984年)。
Neurology. 1993 Oct;43(10):1887-92. doi: 10.1212/wnl.43.10.1887.
6
Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features.美国特定人群中的阿尔茨海默病及其他痴呆性疾病:发病率及临床特征
Ann Neurol. 1987 Dec;22(6):724-9. doi: 10.1002/ana.410220608.
7
Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960-1974.
Neurology. 1988 Jun;38(6):975-80. doi: 10.1212/wnl.38.6.975.
8
Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn.在明尼苏达州罗切斯特市,痴呆症和阿尔茨海默病的发病率并无性别差异。
Arch Neurol. 2002 Oct;59(10):1589-93. doi: 10.1001/archneur.59.10.1589.
9
Risk of dementia among persons with diabetes mellitus: a population-based cohort study.糖尿病患者患痴呆症的风险:一项基于人群的队列研究。
Am J Epidemiol. 1997 Feb 15;145(4):301-8. doi: 10.1093/oxfordjournals.aje.a009106.
10
Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984.痴呆症和阿尔茨海默病的发病率:对明尼苏达州罗切斯特市1975 - 1984年数据的重新分析
Am J Epidemiol. 1998 Jul 1;148(1):51-62. doi: 10.1093/oxfordjournals.aje.a009560.

引用本文的文献

1
Race and Ethnicity and Comorbidities Among Medicare Beneficiaries With Young-Onset Dementia.患有早发性痴呆症的医疗保险受益人的种族、民族与合并症
JAMA Netw Open. 2025 Aug 1;8(8):e2528001. doi: 10.1001/jamanetworkopen.2025.28001.
2
Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis.全球早发性痴呆症的患病率:一项系统评价和荟萃分析。
JAMA Neurol. 2021 Sep 1;78(9):1080-1090. doi: 10.1001/jamaneurol.2021.2161.
3
Change in risk of Alzheimer disease over time.阿尔茨海默病风险随时间的变化。
Neurology. 2010 Aug 31;75(9):786-91. doi: 10.1212/WNL.0b013e3181f0754f.
4
The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.梅奥诊所衰老研究:设计与抽样、参与情况、基线测量及样本特征
Neuroepidemiology. 2008;30(1):58-69. doi: 10.1159/000115751. Epub 2008 Feb 7.
5
Canadian study of health and aging: study methods and prevalence of dementia.加拿大健康与老龄化研究:研究方法及痴呆症患病率
CMAJ. 1994 Mar 15;150(6):899-913.
6
The US economic and social costs of Alzheimer's disease revisited.再探美国阿尔茨海默病的经济和社会成本。
Am J Public Health. 1994 Aug;84(8):1261-4. doi: 10.2105/ajph.84.8.1261.
7
Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: retrospective clinicopathological evaluation of a 10-year autopsy population.一家老年医院1258例患者大脑皮质的神经病理学变化:对10年尸检人群的回顾性临床病理评估
Acta Neuropathol. 1994;87(5):456-68. doi: 10.1007/BF00294172.
8
A mitochondrial DNA clone is associated with increased risk for Alzheimer disease.
Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6892-5. doi: 10.1073/pnas.92.15.6892.